Menu

NSF Calls for Harassment Prevention

The National Science Foundation reiterates its commitment “to eradicate gender-based discrimination in science” with a statement geared toward the institutions it funds.

Jan 27, 2016
Tracy Vence

ISTOCK PHOTO, © ZERNLIEWIn a statement issued this week (January 25), the National Science Foundation (NSF) told grantee institutions it would not tolerate harassment and that it will “will take all appropriate actions to ensure” that those receiving agency funding are compliant with federal antidiscrimination regulations.

“In light of recent, multiple reports of sexual harassment in science, NSF reiterates its unwavering dedication to inclusive workplaces,” the agency noted in its statement. “NSF does not tolerate sexual harassment and encourages members of the scientific community who experience such harassment to report such behavior immediately.”

As Inside Higher Ed noted, the NSF’s announcement followed on the heels of a January 15 letter from NASA Administrator Charles Bolden to grantee institutions. “I urge all of our NASA grantee institutions to examine closely their current policies and procedures for addressing allegations of misconduct such as harassment,” Bolden wrote. “Beyond the law, we must seek to create the kinds of welcoming and supportive program environments in which all students can flourish.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.